AgomAb Therapeutics
AgomAb Therapeutics raised US$88.8M in Series D funding.
Email and contact information
Company website: agomab.com
Decision maker info and email: SIGNUP TO UNBLOCK
Headquarters: , (Belgium)
Industry: Biotechnology, Healthcare
Business model:
Funding
- Total funding amount: $88,829,645 (in USD)
- Estimated valuation: $444,148,225.00
- Latest deal type: Series D
- First fundind year: 2024
Growth
Founders:
Top investors:
Team size: SIGNUP TO UNBLOCK
Revenue: SIGNUP TO UNBLOCK